FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

1145311000001109: Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22454301000001110 Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22454401000001119 Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Is pack of Erythromycin 125mg/5mL s/f suspension false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has active ingredient Erythromycin ethylsuccinate false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has VMP Erythromycin 125mg/5mL s/f suspension false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has specific active ingredient Erythromycin ethylsuccinate true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has VMP Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Has VMP Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erythroped PI SF 125mg/5ml oral suspension (Abbott Laboratories Ltd) 140 ml Is a True Erythromycin ethyl succinate 125mg/5ml oral suspension sugar free 140 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start